Plain-English translation of NCT06155396 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether two medications work together to help women with advanced cervical cancer that has stopped responding to standard platinum-based chemotherapy. The two drugs being tested are (also called RC48-ADC) and . The study will enroll 116 women and track how safe the combination is and whether it shrinks their cancer.
Cervical cancer that comes back or spreads after standard chemotherapy is very difficult to treat, and many women don't have good options. This trial is exploring whether this new two-drug combination might help patients whose cancers have developed resistance to earlier treatments.
You likely qualify if…
You likely don't qualify if…
You would receive the two medications as part of an outpatient treatment plan at one of several study centers. While the exact schedule isn't detailed in this summary, you would have regular visits for the medications, blood tests to check your health and how your body is responding, and imaging scans to measure whether your cancer is shrinking. The study team will closely monitor you for any side effects and keep detailed records of your progress throughout the treatment period.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
China